Drug Repurposing Market Revenue to Attain USD 56.25 Bn by 2033

30 Jun 2025

Share :

Table of Content

1. Drug Repurposing Market Revenue and Trends 2025 to 2033 2. Why is the Drug Repurposing Market Growing Rapidly? 3. Segment Insights 4. Regional Insights 5. Drug Repurposing Market Coverage 6. Drug Repurposing Market Key Players

Drug Repurposing Market Revenue and Trends 2025 to 2033

The global drug repurposing market revenue surpassed USD 36.87 billion in 2025 and is predicted to attain around USD 56.25 billion by 2033, growing at a CAGR of 5.42%. The rising need for cost-effective strategies to speed up drug development and technological innovations in drug discovery and development methods are expected to boost the growth of the market during the forecast period.

Why is the Drug Repurposing Market Growing Rapidly?

The worldwide market for drug repurposing is expanding at a rapid pace, driven by the need for swift and cost-effective drug development. Traditional drug discovery, which is time-consuming and expensive, faces numerous regulatory obstacles. Drug repurposing significantly reduces development costs, timelines, and regulatory hurdles. The urgent need for treatments for chronic and rare diseases is increasing the demand for accelerated therapeutic development, thus boosting market growth. Advances in genomic sciences, bioinformatics, and artificial intelligence are providing more refined insights into potential drug repurposing, along with more precise repurposing methods, opening up new growth avenues for the market.

Drug repurposing is valued by both drug companies and research institutes. Regulatory agencies support it with reimbursement policies and government funding, driving innovation. Increased global health concerns highlight that many existing drugs can address new threats, positioning drug repurposing as a key part of modern drug development.

Segment Insights

• By type of approach, the disease-centric segment held the largest revenue share of the market in 2024. This approach evaluates currently available medications to see if they can achieve a similar pathology through similar mechanistic actions. The increased demand for targeted medications, as a result of the heightened prevalence of life-threatening diseases, further bolstered the segmental growth.
• By therapeutic area, the same therapeutic area segment dominated the market in 2024. Drugs that are repurposed for similar conditions are more effective, making them suitable for treating conditions that remain untreated. Pharmaceutical companies are focusing on repurposing existing medicines so that they can provide innovative treatments for many conditions.
• By drug molecule, the biologics segment contributed the biggest market share in 2024. Biologics are really helpful due to their specificity in treatment and therapeutic benefits.

Regional Insights

North America registered dominance in the drug repurposing market by holding a major share in 2024. The region’s dominance is mainly attributed to its well-established pharmaceutical industry, mature healthcare system, and drug regulations that provide incentives to enable expedited approvals. The rising demand for personalized medicine further supports market growth.

Asia-Pacific is emerging as the fastest-growing market backed by increased healthcare investment, rising patient populations, and rapid innovation in biotechnology. Countries such as China, India, and Japan are becoming centers for low-cost R&D and clinical trials. The rising development of novel drugs, including orphan drugs, is expected to drive regional market growth.

Drug Repurposing Market Coverage

Recent Development

• On March 27, 2025, a new collaboration between ZonMw and FAST: The Drug Repurposing Venture Challenge was launched. This innovative program challenges researchers to transform scientific breakthroughs in drug repurposing into robust plans, ready for market entry and patient benefit - all within three months.
  (Source: https://www.health-holland.com)

Drug Repurposing Market Key Players

• Algernon Pharmaceuticals
• Biovista
• Celentyx Ltd
• ChemBio Discovery, Inc.
• Chord Therapeutics SA
• Excelra
• Fios Genomics
• Lantern Pharma, Inc.
• Novartis AG
• Paradigm Biopharmaceuticals Ltd
• Predictive Oncology
• Segue Therapeutics, LLC
• Sosei Group Corporation
• Teva Pharmaceutical Industries

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6307

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344